Regulation of Fas Ligand Expression By Estrogen in Normal Ovary

被引:0
作者
Eva Sapi
Wendi D. Brown
Sarit Aschkenazi
Chung Lim
Amanda Munoz
Barry M. Kacinski
Thomas Rutherford
Gil Mor
机构
[1] Yale University School of Medicine,Departments of Therapeutic Radiology and Obstetrics and Gynecology, HRT221
来源
The Journal of the Society for Gynecologic Investigation: JSGI | 2002年 / 9卷 / 4期
关键词
Reproductive cycle; 4 hydroxytamoxifen; organ culture; ovarian cancer; apoptosis;
D O I
10.1177/107155760200900411
中图分类号
学科分类号
摘要
引用
收藏
页码:243 / 250
页数:7
相关论文
共 194 条
[1]  
Nagata S(1995)The Fas death factor Science 267 1449-56
[2]  
Golstein P(1999)Fas ligand-induced apoptosis Annu Rev Genet 33 29-55
[3]  
Nagata S(1993)Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family Cell 75 1169-78
[4]  
Suda T(1999)Expression of Fas-Fas ligand in murine testis Am J Reprod Immunol 42 381-8
[5]  
Takahashi T(1995)Fas ligand-induced apoptosis as a mechanism of immune privilege [see comments] Science 270 1189-92
[6]  
Golstein P(1998)Fas-fas ligand system-induced apoptosis in human placenta and gestational trophoblastic disease Am J Reprod Immunol 40 89-94
[7]  
Nagata S(1997)Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells J Clin Endocrinol Metab 82 3173-5
[8]  
Xu JP(1999)FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: Evidence for the existence of an immunological brain barrier Glia 27 62-74
[9]  
Li X(1999)Apoptosis and apoptosis-related proteins in the epithelium of human ovarian tumors: Immunohistochemical and morphometric studies Eur J Gynaecol Oncol 20 249-53
[10]  
Mori E(1999)The Fas/Fas-ligand system: A mechanism for immune evasion in human breast carcinomas Breast Cancer Res Treat 54 245-53